The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Precigen, Inc. Appoints Phil Tennant As Chief Commercial Officer
PUBLIC · PGENJul 23, 2024•almost 2 years ago
Position
Chief Commercial Officer
Company
PRECIGEN, INC.
Phil Tennant
GermantownBiotechnologyHealthcare
Description
Precigen, Inc. announced the appointment of Phil Tennant as the Company's chief commercial officer, who will be responsible for commercial strategy and execution across US and global markets. His initial focus will be on driving commercial readiness activities for the potential launch of the first- and best-in-class PRGN-2012 AdenoVerse gene therapy in recurrent respiratory papillomatosis (RRP).
Company Information
Company
PRECIGEN, INC.
Location
20374 SENECA MEADOWS PARKWAY
Germantown, Illinois, United States
About
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
GermantownBiotechnologyHealthcare